Steeve Néron
Corporate Officer/Principal en TETRA BIO-PHARMA INC. .
Perfil
Steeve Néron is currently the Director at TALLC Corp., Inc. and the Chief Commercial Officer at Tetra Bio-Pharma, Inc. He previously worked as the Senior Portfolio Manager at Valeant Canada Ltd.
from 2013 to 2018.
Mr. Néron completed his undergraduate degree from Université du Québec à Chicoutimi in 1986.
Cargos activos de Steeve Néron
| Empresas | Cargo | Inicio |
|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 17/09/2020 |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Steeve Néron.
| Empresas | Cargo | Fin |
|---|---|---|
Valeant Canada Ltd.
 Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01/02/2018 |
Formación de Steeve Néron.
| Université du Québec à Chicoutimi | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Steeve Néron
